Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

NCT04091217 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Atezolizumab
DRUG: Bevacizumab

Sponsor

Hoffmann-La Roche